ESTRO38 Congress Report
Table of Contents
INTRODUCTION
3
RTT
CLINICAL
34
4
5 46
35 36
INTRODUCTION 1. Implementation of plan of the day adaptive radiotherapy: Compliance to guidelines (E38-1524) 2. Dosimetric benefit of a clinically applied adaptive plan selection strategy for rectal cancer (E38-0922) 3. MERINO study: Defining a standardised delineation method for repeated GTV assessment using DW MRI (E38-2121) INTRODUCTION 1. Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project (E38-1219) 2. Targeting TEMPRSS2:ERG fusion to achieve tumor- specific radiosensitization in prostate cancer (E38-1769) 3. Immunological contextural basis of a prognostic radio- mics signature in head and neck cancers (E38-0734) RADIOBIOLOGY
INTRODUCTION 1. HEAD & NECK Stem cell sparing IMRT for head and neck cancer patients: a double-blind randomized controlled trial (E38-2054) See under awards 2. RECTAL Organ preservation after chemoradiotherapy for rectal cancer: 5-year results of the GRECCAR2 trial (E38-1982) 3. PROSTATE Hyprofractionated vs conventional radiotherapy for prostate cancer: 7 yr results from the HYPROtrial (E38-1311) 4. BREAST Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial (E38-1591) 5. CRANIAL Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC (E38-2563 ) INTRODUCTION 1. MRI-only proton therapy treatment planning with synthetic CT images generated using deep learning (E38-2116) 2. Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer (E38-1852) 3. MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial E38-0898 4. When we have to apply volume corrections in dosimetry? (E38-1668) 5. Correcting CBCT images for dose calculation using a U-shaped deep convolutional neural network (E38-0312) PHYSICS INTRODUCTION 1. BrachyView: A Real-time In-body HDR Source Tracking System with Simultaneous TRUS Image Fusion (E38-0696) 2. Bi-objective optimization of dosimetric indices for HDR prostate brachytherapy within 30 seconds (E38-1275) See under awards 3. Clinical outcomes of focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer (E38-0129) See under awards 4. Single dose high dose-rate (HDR) brachytherapy as monotherapy for localised prostate cancer (E38-0833) 5. 2 nd Conservative Treatment for 2nd Breast Tumor Event: GEC-ESTRO Breast Cancer WG updated results (E38-1734) 6. Contact X-Ray Brachytherapy (CXB) after local excision (LE) for early rectal adenocarcinoma (E38-0234) 7. Performance of ring vs ovoids and intracavitary vs intra- cavitary-interstitial in the EMBRACE study (E38-1266) BRACHYTHERAPY
38
6
39
8
9
40
41 42
11
43
44
12
13 14
AWARDS GRANTED AT ESTRO 38
45
46 47 48 50 52 53
LIST OF AWARDS 1. Donal Hollywood Award 2. Jack Fowler University of Wisconsin Award 3. ESTRO Varian Award 4. Elekta Brachytherapy Award 5. GEC-ESTRO Best Juniour Presentation Elekta Award
16
17
18
19
ACKNOWLEDGEMENTS
55
22
23 24
46
46
26
28
29
30
TABLE OF CONTENTS | Congress report
2
Made with FlippingBook Online newsletter